TCMD (TCMD) revenue breakdown
By product, Lymphedema products is the largest at 84% of fiscal 2025 revenue; Airway clearance products grew fastest, 78% a year over 4 years.
Revenue by product
Fiscal years, as TCMD reports them in its 10-K filings; fiscal 2025 total $330M.
| Products | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Lymphedema products | — | — | — | $171M | — | $203M | $212M | $242M | $259M | $278M | 84% |
| Airway clearance products | — | — | — | — | — | $5M | $35M | $33M | $34M | $51M | 16% |
| Sales revenue | — | — | — | — | $161M | — | — | — | — | — | — |
| Sales revenue | — | — | $129M | — | — | — | — | — | — | — | — |
| Flexitouch system | $73M | $100M | — | — | — | — | — | — | — | — | — |
| Rental revenue | — | — | — | — | $26M | — | — | — | — | — | — |
| Entre system | — | — | — | $18M | — | — | — | — | — | — | — |
| Rental revenue | — | — | $15M | — | — | — | — | — | — | — | — |
| Entre/Actitouch systems | $11M | $9M | — | — | — | — | — | — | — | — | — |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for TCMD.
Open TCMD in InvestinglyQuestions
Where does TCMD make its money?
In fiscal 2025, by product: Lymphedema products $278M, Airway clearance products $51M.
From TCMD's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.